대사 건강 및 연속 혈당 모니터링 시장 예측(-2034년) : 제품 유형, 도입 형태, 연결성 및 통합, 유통 채널, 용도, 최종사용자, 지역별 세계 분석

According to Stratistics MRC, the Global Metabolic Health & Continuous Glucose Monitoring Market is accounted for $10.0 billion in 2026 and is expected to reach $26.3 billion by 2034 growing at a CAGR of 12.8% during the forecast period. Metabolic Health & Continuous Glucose Monitoring covers solutions designed to monitor glucose levels, interpret metabolic trends, and encourage healthier lifestyle choices. Wearable continuous glucose monitoring devices deliver ongoing glucose measurements, allowing users and clinicians to recognize changes and patterns more effectively. The market includes monitoring technologies, connected digital platforms, data analytics, and personalized health programs. Increasing interest in preventive care, metabolic wellness, personalized nutrition, and digitally supported health management is driving broader use among individuals managing diabetes as well as consumers focused on proactive metabolic health.

According to WHO, diabetes prevalence among adults aged 18 years and older increased from 6.8% in 1990 to 14.1% in 2022, supporting demand for technologies that enable glucose monitoring and diabetes management.

Market Dynamics:

Driver:

Rising prevalence of diabetes and metabolic disorders

Growing rates of diabetes and metabolic health conditions are supporting demand for continuous glucose monitoring solutions. CGM technologies provide ongoing glucose measurements that help users recognize changes and make informed adjustments to diet, activity, or treatment. Their role is also expanding from conventional diabetes management toward broader preventive healthcare. Healthcare professionals can use continuous glucose information to develop more personalized care approaches, while consumers increasingly explore glucose monitoring for nutrition, exercise, weight management, and general wellness. This wider interest is creating additional opportunities for metabolic health monitoring technologies.

Restraint:

High cost of continuous glucose monitoring devices

High expenses associated with CGM systems can constrain the expansion of the Metabolic Health & Continuous Glucose Monitoring Market. Costs may include wearable sensors, transmitters, subscriptions, and digital services, while sensor replacement creates recurring financial commitments. Inadequate reimbursement or limited healthcare coverage can further increase the burden for users paying independently. Consequently, price-conscious consumers may hesitate to adopt continuous monitoring technologies, especially when traditional glucose testing provides a lower-cost alternative. These affordability challenges can slow adoption among underserved populations and limit penetration in markets where healthcare spending remains comparatively constrained.

Opportunity:

Expansion of CGM applications beyond diabetes management

The broader use of CGM technologies beyond conventional diabetes care presents opportunities for market expansion. Continuous glucose data can help users understand relationships between glucose patterns, food intake, exercise, sleep, and everyday behaviors. Increasing interest in preventive healthcare and personalized wellness could support adoption among consumers without diagnosed diabetes. Partnerships with nutrition services, fitness applications, weight-management programs, and digital wellness platforms may expand the role of CGM solutions. Such integration can create additional demand and enable manufacturers and healthcare technology companies to develop new metabolic health offerings.

Threat:

Cybersecurity risks and unauthorized health data access

Cybersecurity concerns may challenge the growth of the Metabolic Health & Continuous Glucose Monitoring Market because connected CGM systems handle sensitive health information. Security weaknesses, unauthorized access, or breaches involving devices, applications, or cloud platforms could compromise user data and affect confidence in digital monitoring solutions. Greater integration among CGM devices, smartphones, healthcare platforms, and cloud infrastructure can increase exposure to cybersecurity threats. Manufacturers and service providers may consequently face rising requirements for security investments, privacy safeguards, regulatory compliance, and ongoing system protection to preserve consumer trust.

Covid-19 Impact:

COVID-19 highlighted the importance of metabolic health and remote glucose monitoring as healthcare services experienced interruptions and fewer face-to-face consultations. CGM systems became increasingly useful by enabling patients and clinicians to access glucose information remotely. However, lockdown measures, disrupted supply chains, manufacturing difficulties, and limited healthcare access created challenges for product availability and adoption across certain markets. The pandemic simultaneously accelerated telemedicine and digital health usage, creating stronger foundations for incorporating continuous glucose monitoring into remote patient care, diabetes management, and personalized metabolic health services.

The sensors segment is expected to be the largest during the forecast period

The sensors segment is expected to account for the largest market share during the forecast period because they serve as the fundamental technology enabling continuous glucose measurement. They allow CGM systems to obtain glucose readings from interstitial fluid and support the transfer of information to connected devices and software platforms. Growing preference for continuous and real-time glucose monitoring has increased the importance of advanced sensor technologies. Improvements in sensor precision, compact design, comfort, wearability, and usage duration are also strengthening their role in CGM solutions used for diabetes management and expanding metabolic health monitoring applications.

The fitness & wellness centers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the fitness & wellness centers segment is predicted to witness the highest growth rate as consumers increasingly focus on preventive healthcare, personalized fitness, and metabolic wellness. These settings can use CGM technologies to support individualized nutrition, exercise, weight-management, and lifestyle programs. Greater consumer interest in understanding glucose responses to meals and physical activity is creating opportunities for broader CGM use. Connecting glucose information with fitness applications and wellness platforms can provide personalized insights, encourage healthier behaviors, and strengthen the adoption of continuous metabolic monitoring solutions across wellness-oriented environments.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by established healthcare systems, broad adoption of digital health technologies, and increasing utilization of CGM solutions. Strong awareness of diabetes management supports demand across the region. The United States is a key contributor, supported by its substantial diabetes population, developed healthcare infrastructure, insurance coverage, and strong CGM industry presence. Greater connectivity between glucose monitors, smartphones, remote-care platforms, and personalized health services is also supporting continued development of the regional market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by rising diabetes prevalence, improving healthcare systems, and greater use of digital health solutions. Growing awareness of glucose control and preventive wellness is supporting interest in continuous monitoring. Regional healthcare systems are increasingly integrating digital technologies into diabetes management and primary care. Expanding investment in connected medical devices, remote healthcare, and personalized treatment approaches is expected to create additional opportunities for CGM technologies and metabolic health monitoring across the region.

Key players in the market

Some of the key players in Metabolic Health & Continuous Glucose Monitoring Market include Abbott Laboratories, Dexcom, Medtronic, Senseonics Holdings, Roche Diagnostics, Ascensia Diabetes Care, Medtrum Technologies, i-SENS, Nemaura Medical, Bionime Corporation, Zhejiang POCTech, Biolinq, Ultrahuman, GlySens, Levels Health, Nutrisense, January AI and Signos.

Key Developments:

In February 2026, Medtronic has agreed to acquire CathWorks, an Israeli medtech company focused on the diagnosis and treatment of coronary artery disease, for up to $585 million. CathWorks is known for its FFRangio technology, which uses advanced artificial intelligence (AI) algorithms and computational science to obtain fractional flow reserve (FFR) measurements of the coronary tree from routine X-ray images.

In November 2025, Abbott and Exact Sciences announced a definitive agreement for Abbott to acquire Exact Sciences, which will enable it to enter and lead in fast-growing cancer diagnostics segments, serving millions more people. Under the terms of the agreement, Exact Sciences shareholders will receive $105 per common share, representing a total equity value of approximately $21 billion.

Product Types Covered:

• Devices
• Sensors
• Software & Apps

Deployment Modes Covered:

• Wearable Systems
• Implantable Systems

Connectivity & Integrations Covered:

• Smartphone-Integrated
• Cloud-Based Platforms
• Standalone Devices

Distribution Channels Covered:

• Retail Pharmacies
• Hospital Pharmacies
• Online Platforms

Applications Covered:

• Diabetes Management
• Obesity & Weight Management
• Preventive Metabolic Monitoring
• Sports & Performance Optimization

End Users Covered:

• Hospitals & Clinics
• Homecare Settings
• Fitness & Wellness Centers

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Metabolic Health & Continuous Glucose Monitoring Market, By Product Type

• 5.1 Devices
• 5.2 Sensors
• 5.3 Software & Apps

6 Global Metabolic Health & Continuous Glucose Monitoring Market, By Deployment Mode

• 6.1 Wearable Systems
• 6.2 Implantable Systems

7 Global Metabolic Health & Continuous Glucose Monitoring Market, By Connectivity & Integration

• 7.1 Smartphone-Integrated
• 7.2 Cloud-Based Platforms
• 7.3 Standalone Devices

8 Global Metabolic Health & Continuous Glucose Monitoring Market, By Distribution Channel

• 8.1 Retail Pharmacies
• 8.2 Hospital Pharmacies
• 8.3 Online Platforms

9 Global Metabolic Health & Continuous Glucose Monitoring Market, By Application

• 9.1 Diabetes Management
• 9.2 Obesity & Weight Management
• 9.3 Preventive Metabolic Monitoring
• 9.4 Sports & Performance Optimization

10 Global Metabolic Health & Continuous Glucose Monitoring Market, By End User

• 10.1 Hospitals & Clinics
• 10.2 Homecare Settings
• 10.3 Fitness & Wellness Centers

11 Global Metabolic Health & Continuous Glucose Monitoring Market, By Geography

• 11.1 North America
  • 11.1.1 United States
  • 11.1.2 Canada
  • 11.1.3 Mexico
• 11.2 Europe
  • 11.2.1 United Kingdom
  • 11.2.2 Germany
  • 11.2.3 France
  • 11.2.4 Italy
  • 11.2.5 Spain
  • 11.2.6 Netherlands
  • 11.2.7 Belgium
  • 11.2.8 Sweden
  • 11.2.9 Switzerland
  • 11.2.10 Poland
  • 11.2.11 Rest of Europe
• 11.3 Asia Pacific
  • 11.3.1 China
  • 11.3.2 Japan
  • 11.3.3 India
  • 11.3.4 South Korea
  • 11.3.5 Australia
  • 11.3.6 Indonesia
  • 11.3.7 Thailand
  • 11.3.8 Malaysia
  • 11.3.9 Singapore
  • 11.3.10 Vietnam
  • 11.3.11 Rest of Asia Pacific
• 11.4 South America
  • 11.4.1 Brazil
  • 11.4.2 Argentina
  • 11.4.3 Colombia
  • 11.4.4 Chile
  • 11.4.5 Peru
  • 11.4.6 Rest of South America
• 11.5 Rest of the World (RoW)
  • 11.5.1 Middle East
    • 11.5.1.1 Saudi Arabia
    • 11.5.1.2 United Arab Emirates
    • 11.5.1.3 Qatar
    • 11.5.1.4 Israel
    • 11.5.1.5 Rest of Middle East
  • 11.5.2 Africa
    • 11.5.2.1 South Africa
    • 11.5.2.2 Egypt
    • 11.5.2.3 Morocco
    • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

• 12.1 Industry Value Network and Supply Chain Assessment
• 12.2 White-Space and Opportunity Mapping
• 12.3 Product Evolution and Market Life Cycle Analysis
• 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

• 13.1 Mergers and Acquisitions
• 13.2 Partnerships, Alliances, and Joint Ventures
• 13.3 New Product Launches and Certifications
• 13.4 Capacity Expansion and Investments
• 13.5 Other Strategic Initiatives

14 Company Profiles

• 14.1 Abbott Laboratories
• 14.2 Dexcom
• 14.3 Medtronic
• 14.4 Senseonics Holdings
• 14.5 Roche Diagnostics
• 14.6 Ascensia Diabetes Care
• 14.7 Medtrum Technologies
• 14.8 i-SENS
• 14.9 Nemaura Medical
• 14.10 Bionime Corporation
• 14.11 Zhejiang POCTech
• 14.12 Biolinq
• 14.13 Ultrahuman
• 14.14 GlySens
• 14.15 Levels Health
• 14.16 Nutrisense
• 14.17 January AI
• 14.18 Signos